首页>生物医学与环境科学(英文版)>Improved Specificity for Breast Cancer Screening Using an Oncogenic(miRNA-21)and a Gene Suppressor(miRNA-195)miRNA in the Serum for a Point of Care(POC)Screening Solution
Improved Specificity for Breast Cancer Screening Using an Oncogenic(miRNA-21)and a Gene Suppressor(miRNA-195)miRNA in the Serum for a Point of Care(POC)Screening Solution
摘要The overall incidence and burden caused by breast cancer is increasing, affecting the global socio-economic development and life expectancy[1]. According to "WHO Global Breast Cancer Initiative (GBCI) reports", if the mortality rate due to breast cancer can be reduced by 2.4% annually, we may prevent 2.5 million breast cancer deaths between 2020-2040.
作者单位PSG Institute of Advanced Studies,Avinashi Road,Peelamedu,Coimbatore,641004[1]PSG Institute of Medical Science and Research Avinashi Road,Peelamedu,Coimbatore,641004[2]PSG Center for Molecular Medicine and Therapeutics,PSG Institute of Medical Sciences and Research,Coimbatore,Tamil Nadu,641004,India;PSG Centre for Genetics and Molecular Biology,Off Avinashi Road,Peelamedu,Coimbatore,Tamil Nadu,641004,India[3]